Projects funded by the NCN
Definition of targetable signaling pathways in chronic lymphocytic leukemia patients with rationale to novel therapy with EZH2 inhibition
2018/31/N/NZ5/03344
Keywords:
chronic lymphocytic leukemia personalized medicine targeted therapy next-generation sequencing EZH2 mutation
Descriptors:
- NZ5_7:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 16 - announced on 2018-09-14
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2019-08-12
Project end date (Y-m-d): 2025-08-11
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.